18 Va. Admin. Code § 85-21-160

Current through Register Vol. 40, No. 22, June 17, 2024

Section 18VAC85-21-160 - Special populations in addiction treatment

A. Pregnant women may be treated with the buprenorphine mono-product, usually 16 milligrams per day or less.

B. Patients younger than the age of 16 years shall not be prescribed buprenorphine for addiction treatment unless such treatment is approved by the FDA.

C. The progress of patients with chronic pain shall be assessed by reduction of pain and functional objectives that can be identified, quantified, and independently verified.

D. Practitioners shall (i) evaluate patients with medical comorbidities by history, physical exam, [ and ] appropriate laboratory studies and (ii) be aware of interactions of buprenorphine with other prescribed medications.

E. Practitioners shall not undertake buprenorphine treatment with a patient who has psychiatric comorbidities and is not stable. A patient who is determined by the prescriber to be psychiatrically unstable shall be referred for psychiatric evaluation and treatment prior to initiating medication-assisted treatment.

18 Va. Admin. Code § 85-21-160

Derived From Virginia Register Volume 34, Issue 23, eff. 8/8/2018.

Statutory Authority: §§ 54.1-2400 and 54.1-2928.2 of the Code of Virginia.